BioTech 365

OCTOBER 8, 2020

Senior Vice President, Business Development, will present at the annual 2020 Cell & Gene Virtual Meeting on the Mesa. BURLINGTON, Mass., 08, 2020 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. Nasdaq:FLXN) announced today that Adam Muzikant, Ph.D., Dr. Muzikant will provide a … Continue reading →

Gene 40

Gene Business Development Development 40

BioPharma Reporter

MAY 15, 2024

Before the industry is set to arrive in San Diego for Bio International 2024, we spoke with Dr. Harald Oberegger, global head business development at Novartis Contract Manufacturing.

Manufacturing 52

Manufacturing Contract Manufacturing Gene Therapy Business Development 52

pharmaphorum

SEPTEMBER 21, 2021

Fortunately, we are now experiencing significant progress in gene therapy and other platform approaches targeting rare diseases, with a number of them focused on devastating CNS conditions. This is and should be a priority for our health system. We need to work together to solve it. About the author.

Gene Therapy 90

Gene Therapy Gene Clinical Trials Clinical Trials 90

The Pharma Data

JUNE 7, 2023

Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics Bayer AG is joining forces with Acuitas Therapeutics, Inc., a biotechnology company specializing in the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics. Financial details were not disclosed.

Gene Therapy 40

Gene Therapy Gene Gene Editing In-Vivo 40

pharmaphorum

AUGUST 8, 2022

CRISPR Therapeutics and Vertex are also in the running with their gene-editing candidate CTX001, in phase 1/2 trials which are due to generate final results later this year. If those results are positive the partners have said they could file for approval in the US before year-end. It comes shortly after the group closed a $6.7

Marketing 111

Marketing Sales Gene Editing Antibody 111

Pharmaceutical Technology

SEPTEMBER 15, 2022

The increase in the production of biological drugs such as vaccines, gene and cell therapies, and monoclonal antibodies, is increasing the volume of injectable drug products in the global healthcare market.

Marketing 100

Marketing Containment Production Sales 100

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. and France to accelerate the development of genomic therapies. The evolving field of genomic medicine.

Genome 105

Genome Genomics Medicine Development 105

The Pharma Data

OCTOBER 20, 2020

CureLab has appointed Jihad Fakhreddine as director of business development, representing CureLab in the region. After 20+ years of successful business development in the USA and Switzerland , he moved to Dubai to lead international healthcare and fundraising projects.

DNA 52

DNA Business Development Production Gene 52

The Pharma Data

OCTOBER 15, 2020

The committee is tasked with supporting BeyondSpring’s business development activities related to its lead asset, Plinabulin, and other pipeline assets. Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc., Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc.,

In-Vivo 52

In-Vivo Business Development Manufacturing Development 52

Imperical Blog

MAY 20, 2020

Dan McDonald, vice president, global business development. Imogen Cheese, Imperial director of business development, U.K. Wearables will be developed that notify patients and EMS services of precursors to adverse events. Gene counselors and genetic testing. Instead we are blasting forward at record pace.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Genetics 52

pharmaphorum

SEPTEMBER 28, 2022

” ArsenalBio’s platform makes use of automation, large-scale genome engineering, using technologies like CRISPR-based gene-editing, and machine learning and artificial intelligence algorithms to design, build, and test cell therapies.

Gene Editing 59

Gene Editing Genome Genomics Engineer 59

pharmaphorum

JANUARY 13, 2023

Sanofi Ventures invests in innovators working in areas including immunology and inflammation, rare diseases, oncology, cell and gene therapy, vaccines, and digital health and data science.

Gene Therapy 52

Gene Therapy Business Development Gene Vaccine 52

pharmaphorum

OCTOBER 1, 2021

It has made Oxford Nanopore’s chief executive and cofounder Gordon Sanghera an on-paper fortune of £63 million, while another cofounder – chief business development officer Spike Willcocks – is now worth £30 million. Chief technology officer Clive Brown is also sitting on a £10 million stake.

Marketing 52

Marketing Genome Genomics Business Development 52

pharmaphorum

DECEMBER 16, 2022

Maishman brings a wealth of experience to the cell and gene therapy-focused company, having worked at GlaxoSmithKline, Pfizer, Valneva, Alexion, and Recipharm in various leadership roles. Reagents supplier The Native Antigen Company has hired a new business development manager, Richard White , and senior product manager, Pardeep Sharda.

Behavioural Health 52

Behavioural Health Reagent Gene Therapy Production 52

Pharmaceutical Technology

DECEMBER 22, 2022

The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic business development prospects. Be Bio Blueprint Medicines Endeavor BioMedicines Kallyope Metagenomi Mineralys Neuron23 Nutcracker RayzeBio Rivus Ventus Therapeutics. Innovation.

Insulin 130

Insulin Production Development Genetics 130

The Pharma Data

DECEMBER 3, 2020

Barnett joined Array in 2000, two years after the company was founded, and played an invaluable role in successfully bringing Mektovi and Braftovi, two precision oncology medicines, to market while serving in a range of roles including research, business development and technical operations. Liquidia Corporation – N.C. Source link.

Development 52

Development Business Development Manufacturing Clinical Development 52

The Pharma Data

DECEMBER 17, 2020

SpringWorks Therapeutics — Badreddin Edris has been promoted from chief business officer to COO and Mary Smith, Mary Smith, currently senior vice president of Clinical Research and Development, has been promoted to chief development officer at SpringWorks. Rinri Therapeutics – Terri Gaskell was named CTO of U.K.-based

Development 52

Development Gene Therapy Engineer Life Science 52

The Pharma Data

NOVEMBER 3, 2020

In addition, LogicBio has a collaboration with Takeda to research and develop LB-301, an investigational therapy leveraging GeneRide for the treatment of the rare pediatric disease Crigler-Najjar syndrome. LogicBio is also developing a Next Generation Capsid platform for use in gene editing and gene therapies.

Clinical Trials 40

Clinical Trials Clinical Trials Gene Editing Genome 40

XTalks

MAY 17, 2024

Prior to joining Calliditas Therapeutics as CMO, he held roles at GlaxoSmithKline (GSK) and Takeda, focusing on clinical and business development in rare diseases. I’ve had a great passion for drug development in rare diseases,” says Dr. Philipson, underscoring a commitment that would shape his career’s trajectory.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

XTalks

AUGUST 2, 2023

They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

NOVEMBER 5, 2020

Velders is presently chairman of HollandBIO, the association of Dutch biotech companies, and provides years of experience, specifically in the cell and gene therapy areas. Before joining Kite, he was chief scientific officer at Dutch AM-Pharma, Business Unit Manager at TNO Biosciences and chief executive officer at SomantiX.

Genome 40

Genome Genomics Medicine Life Science 40

The Pharma Data

AUGUST 3, 2021

Aimovig retains strong payer coverage and remains the segment leader within the preventive calcitonin gene-related peptide (CGRP) class. R&D expenses increased 11% primarily due to higher research and early pipeline spend and late-stage development program spend, including our recent business development activities.

Sales 52

Sales Production Antibody Development 52

Pharmaceutical Technology

JANUARY 26, 2023

Cell and gene therapies are predicted to be the future of medical treatment by providing the body with the means to repair itself and recover from a range of serious conditions and severe diseases. While cell and gene therapies are currently much more expensive than traditional medical treatments, the ultimate savings could be significant.

Gene Therapy 130

Gene Therapy Gene Medicine Manufacturing 130

Pharmaceutical Technology

MARCH 20, 2023

Research – and money – going into even more advanced gene therapies is ramping up. Genomics is set to have a major impact on understanding, preventing, and treating a huge range of diseases; cell and gene therapies will bolster oncology investment, for example, with several such drugs currently in development.

Gene Therapy 225

Gene Therapy Genome Genomics Gene 225

Pharmaceutical Technology

MAY 9, 2023

The purchase of Viroclinics-DDL, an established global specialist virology and vaccine development contract research organisation, gives Cerba Research the opportunity to enhance solutions across therapeutic areas, explore new geographies and build best-in-class logistics services, while reducing risks for customers.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130

Drug Discovery World podcast

DECEMBER 5, 2024

They are called: “ Accelerating time to market through digitalisation ”, “ Why digital biomarkers will power tomorrow’s Alzheimer’s therapies ”, and “ The path to improved safety of gene-based products ”. The post The far-reaching impact of drug discovery technology appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Gene Therapy Gene Business Development 52